D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
BEAM holding history
Beam Therapeutics Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BEAM overviewAll 13F holders of BEAMFull Q2 2026 holdings
- Shares (Q2 2026)
- 130,577
- Value
- $4.48M
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 130,577 | $4.48M | <0.1% | +130,577 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −27,935−100.0% | Sold out | Holders |
| Q4 2025 | 27,935 | $774.4K | <0.1% | +27,935 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −8,721−100.0% | Sold out | Holders |
| Q2 2024 | 8,721 | $204.3K | <0.1% | +8,721 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −43,995−100.0% | Sold out | Holders |
| Q3 2022 | 43,995 | $2.10M | <0.1% | +43,995 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −17,269−100.0% | Sold out | Holders |
| Q4 2021 | 17,269 | $1.38M | <0.1% | −41,974−70.9% | Reduced | Holders |
| Q3 2021 | 59,243 | $5.16M | <0.1% | +59,243 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −6,196−100.0% | Sold out | Holders |
| Q1 2021 | 6,196 | $496.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.